Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
FDA Revokes Approval For Three Potentially Toxic Chemicals Used in Food Wrappers January 7, 2016 Russell Maas Add Your Comments In response to a Food Additive Petition filed by several major health organizations, federal regulators have revoked approval for three chemicals for use as grease-proofing agents that coat paper wrappers and containers, due to growing health concerns that the agents may contaminate food items and cause reproductive system complications. The FDA issued a notice on January 4, indicating that three long-chain perfluorinated compounds (PFCs) can no longer be used in food wrappers. The decision follows a comprehensive review of potential health hazards detailed in current literature, which has found the direct contact of the chemicals with food items could lead to contamination and disruption of the male and female reproductive organs. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The FDA banned the three long-chain PFCs in response to a Food Additive Petition filed by the Natural Resources Defense Council, the Center for Food Safety, the Breast Cancer Fund, the Center for Environmental Health, Clean Water Action, the Center for Science in the Public Interest, the Children’s Environmental Working Group, and Improving Kids’ Environment. The Food Additive Petition was filed with the FDA in October 2014, in an effort to ban the use of diethanolamine salts of mono- and bis, pentanoic acid, 4,4-bis, and perfluoroalkyl substituted phosphate ester acids that contain perfluoroalkyl ethyl. The petition targeted the use of the PFCs as grease and water repellants for containers and paperboard that come into contact with foods, such as pizza packaged in boxes, microwave popcorn, fast-food packaging, and pet food bags. PFC Toxicity Concerns Researchers from the U.S. and Europe say that perfluorinated compounds (PFCs) are a form of contaminant frequently present in the environment, but whose effects on the human body are not well understood. According to the petition, research has indicated the PFCs coming into direct contact with food products are toxic. The organizations claimed in their petition that evidence presented in a 2010 FDA memorandum indicated PFC exposure was shown to cause reproductive and developmental toxicity in tested animal models. According to findings published in the Journal of the American Medical Association in 2012, PFC exposure may also suppress the immune system and limit the ability of the body to create antibodies in response to childhood vaccines. The FDA first authorized the use of several long-chain PFCs as grease proofing agents prior to 2000 before any safety concerns had surfaced. In 2010, when safety concerns and lab tests began indicating the potential toxicity levels PFCs may pose to consumers, the agency reached out to the packaging industry leaders to stop the use of the long-chain PFCs used in the most common food packaging at that time. Following the petition and further pressure from consumer health organizations, the FDA launched an independent investigation into possible health concerns from long chain PFC exposure. Their results raised significant questions as to whether PFC exposure is safe for consumers. Given the findings, the FDA ordered the removal of the chemicals due to the “reasonable certainty of no harm” standards used for approving chemicals in food items. Due to the reasonable certainty that exposure to long chain PFCs in food items may cause health problems due to the toxicity, the FDA is revoking its previously approved use of PFCs for food packaging. Although leaders from the petitioning organizations seem pleased with the FDA’s decision, some say the agency’s actions were delayed and should have been acted upon years ago, noting that it has taken the FDA more than 10 years to figure out these chemicals are harmful to consumers and that the three PFCs officially banned from production are hardly even used any more. Tags: Food, Perflourinated Compounds (PFCs) More Lawsuit Stories Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker March 19, 2025 AngioDynamics Lawsuit Claims Xcela Port Catheter Caused Acute Embolism March 19, 2025 Amazon Challenges Responsibility To Notify Customers About Recalled Products March 19, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (Posted: today) A federal judge has appointed the BioZorb lawyers to serve in various leadership positions during coordinated pretrial proceedings in the rapidly growing litigation, taking actions that benefit all plaintiffs pursuing a claim against Hologic. MORE ABOUT: BIOZORB LAWSUITBreast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025) Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (Posted: yesterday) A federal judge is expediting Depo-Provera brain tumor lawsuits towards resolution by permitting direct filing of new claims with the MDL court and appointing numerous plaintiffs’ attorneys to leadership roles. MORE ABOUT: DEPO-PROVERA LAWSUIT75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025) Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (Posted: 2 days ago) The U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITSuboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (03/11/2025)Medical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)
Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker March 19, 2025
Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (Posted: today) A federal judge has appointed the BioZorb lawyers to serve in various leadership positions during coordinated pretrial proceedings in the rapidly growing litigation, taking actions that benefit all plaintiffs pursuing a claim against Hologic. MORE ABOUT: BIOZORB LAWSUITBreast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)
Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (Posted: yesterday) A federal judge is expediting Depo-Provera brain tumor lawsuits towards resolution by permitting direct filing of new claims with the MDL court and appointing numerous plaintiffs’ attorneys to leadership roles. MORE ABOUT: DEPO-PROVERA LAWSUIT75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025)
Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (Posted: 2 days ago) The U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITSuboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (03/11/2025)Medical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)